Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Blood Stem Cell Transplant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT07458854
What this trial is testing

Exercise in Patients Undergoing Autologous Stem Cell Transplantation: A Randomized Controlled Trial

Who this might be right for
Hematologic MalignacyAutologous Hematopoietic Stem Cell Transplantation
TC Erciyes University 15
Testing effectiveness (Phase 2)Study completedNCT00003146
What this trial is testing

Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Fred Hutchinson Cancer Center
Not applicableUnknownNCT05218603
What this trial is testing

Evaluation of Maintenance With Bortezomib Plus Daratumumab (V-Dara) After Induction With Bortezomib, Melphalan, Prednisone Plus Daratumumab (VMP-Dara) in Newly Diagnosed Multiple Myeloma (MM) Patients Non-eligible for autoSCT

Who this might be right for
Multiple MyelomaNon-eligible for Autologous Stem Cell Transplantation (ASCT)
PETHEMA Foundation 100
Early research (Phase 1)WithdrawnNCT02378922
What this trial is testing

Gene-Modified HIV-Protected Stem Cell Transplant in Treating Patients With HIV-Associated Lymphoma

Who this might be right for
AIDS-Related Hodgkin LymphomaAIDS-Related Non-Hodgkin LymphomaHIV Infection+2 more
Fred Hutchinson Cancer Center
Not applicableStudy completedNCT00003538
What this trial is testing

Prevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation

Who this might be right for
Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Early research (Phase 1)Ended earlyNCT00469820
What this trial is testing

Vaccine Therapy With or Without Donor Lymphocyte Infusion in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Multiple Myeloma Undergoing Donor Stem Cell Transplant

Who this might be right for
LeukemiaMultiple Myeloma and Plasma Cell Neoplasm
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 1
Testing effectiveness (Phase 2)Ended earlyNCT00548717
What this trial is testing

Sirolimus, Mycophenolate Mofetil and Bortezomib as Graft-Versus-Host Disease (GVHD) Prophylaxis After Reduced Intensity Conditioning (RIC) Hematopoietic Stem Cell Transplantation

Who this might be right for
Graft-vs-Host Disease
Dana-Farber Cancer Institute 15
Large-scale testing (Phase 3)Study completedNCT00002755
What this trial is testing

Standard Chemotherapy Compared With High-Dose Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer

Who this might be right for
Breast Cancer
Scottish Cancer Therapy Network 600
Not applicableStudy completedNCT02398708
What this trial is testing

Comparison of Gut Microbiota, Inflammation and Symptoms Following Allogeneic HSCT

Who this might be right for
Graft vs Host DiseaseGraft Versus Host DiseaseHematopoietic Stem Cell Transplantation+1 more
University of Florida 38
Not applicableNot Yet RecruitingNCT07563920
What this trial is testing

TBF Conditioning Regimen for Haploidentical Stem Cell Transplantation in Elderly AML Patients in First Complete Remission

Who this might be right for
Acute Myeloid Leukemia
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 93
Large-scale testing (Phase 3)Ended earlyNCT00324324
What this trial is testing

Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
OHSU Knight Cancer Institute 240
Testing effectiveness (Phase 2)WithdrawnNCT00723658
What this trial is testing

S0629, Observation or Combination Chemotherapy, Bortezomib, Thalidomide, and Rituximab Followed By Two Autologous Peripheral Blood Stem Cell Transplants in Treating Patients With Waldenstrom Macroglobulinemia

Who this might be right for
Lymphoma
SWOG Cancer Research Network
Testing effectiveness (Phase 2)Study completedNCT04552743
What this trial is testing

MGTA-145 + Plerixafor in the Mobilization of Hematopoietic Stem Cells for Autologous Transplantation in Multiple Myeloma

Who this might be right for
Multiple Myeloma
Surbhi Sidana, MD 25
Testing effectiveness (Phase 2)UnknownNCT04582604
What this trial is testing

Ruxolitinib and Decitabine for High Risk Hematological Malignancies

Who this might be right for
Peripheral Blood Stem Cell Transplantation
Chinese PLA General Hospital 60
Testing effectiveness (Phase 2)Looking for participantsNCT03520647
What this trial is testing

Haplo-identical Transplantation for Severe Aplastic Anemia, Hypo-plastic MDS and PNH Using Peripheral Blood Stem Cells and Post-transplant Cyclophosphamide for GVHD Prophylaxis

Who this might be right for
Severe Aplastic Anemia (SAA)Hypo-Plastic Myelodysplastic Syndrome (MDS)Paroxysmal Nocturnal Hemoglobinuria (PNH)
National Heart, Lung, and Blood Institute (NHLBI) 56
Testing effectiveness (Phase 2)Study completedNCT00561743
What this trial is testing

A Study Assessing Safety and Effectiveness of BORTEZOMIB Combination Therapy (Bortezomib + Doxorubicin Hydrochloride + Dexamethasone) in Previously Untreated Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
Janssen-Ortho Inc., Canada 50
Testing effectiveness (Phase 2)Looking for participantsNCT05436418
What this trial is testing

The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation

Who this might be right for
Peripheral Blood Stem Cell TransplantationHematopoietic Stem Cell Transplantation
National Cancer Institute (NCI) 260
Early research (Phase 1)Study completedNCT02431208
What this trial is testing

Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) Alone or in Combination With an Immunomodulatory Drug and/or Daratumumab in Participants With Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
Hoffmann-La Roche 85
Testing effectiveness (Phase 2)Active Not RecruitingNCT02861417
What this trial is testing

Busulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmHigh Risk Acute Myeloid LeukemiaHigh Risk Myelodysplastic Syndrome+11 more
M.D. Anderson Cancer Center 204
Testing effectiveness (Phase 2)Study completedNCT01009840
What this trial is testing

IV Busulfan Plus Bortezomib Conditioning Regimen for Second Autologous Stem Cell Transplant in Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
Otsuka Pharmaceutical Development & Commercialization, Inc. 30
Next Page